Scancell (LON:SCLP) Trading 11% Higher - Here's Why

Scancell Holdings plc (LON:SCLP - Get Free Report)'s share price was up 11% during mid-day trading on Tuesday . The stock traded as high as GBX 11.65 ($0.16) and last traded at GBX 11.65 ($0.16). Approximately 2,178,450 shares changed hands during trading, an increase of 122% from the average daily volume of 982,787 shares. The stock had previously closed at GBX 10.50 ($0.14).

Scancell Stock Down 5.3 %

The firm has a market cap of £110.30 million, a price-to-earnings ratio of -16.33 and a beta of 0.35. The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The firm has a fifty day moving average price of GBX 8.77 and a 200-day moving average price of GBX 10.74.

Scancell (LON:SCLP - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. As a group, sell-side analysts forecast that Scancell Holdings plc will post -2.5361112 EPS for the current year.

Scancell Company Profile

Scancell LSE: SCLP is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers. Scancell has developed a pipeline of ‘off-the-shelf' vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.